Boundless Bio (BOLD) Posts First Revenue of $17.3M, Narrows Q4 Loss to $0.58/Share
Boundless Bio narrows Q4 loss to $0.58/share and posts first-ever revenue of $17.3M, guiding...
Breaking news, market updates, and exclusive interviews
Boundless Bio narrows Q4 loss to $0.58/share and posts first-ever revenue of $17.3M, guiding...
Korn Ferry posted Q3 adjusted EPS of $1.28, down 7.6% year-over-year, as revenue of...
CEO Carsten Brunn sold 23,766 shares at $6.82 per share, totaling $162,077, while retaining...
Repay posts $0.24 adjusted EPS on flat $77.7M revenue, with GAAP loss of $6.6M...
CMCT reports Q4 loss of $11.20/share, matching prior quarter but widening sharply from $0.37/share...
ACCO Brands posts Q4 adjusted EPS of $0.38, flat sequentially but down 2.6% year-over-year,...
TL;DR: Costco’s latest earnings beat expectations, reinforcing the narrative that the U.S. consumer is still spending but the market is...
Dr. Shalabh Gupta, CEO of Unicycive Therapeutics, discusses the company’s focus on kidney care and its lead drug candidate for...